These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 29463381

  • 1. Photocarcinogenic Risk Associated With Narrowband UV-B Phototherapy: An Epidemiologic Study in a Tertiary Care Hospital.
    Ortiz-Salvador JM, Ferrer DS, Saneleuterio-Temporal M, Victoria Martínez AM, Ferriols AP, Vilata Corell JJ, Alegre de Miquel V.
    Actas Dermosifiliogr (Engl Ed); 2018 May; 109(4):340-345. PubMed ID: 29463381
    [Abstract] [Full Text] [Related]

  • 2. The challenge of follow-up in narrowband ultraviolet B phototherapy.
    Diffey BL, Farr PM.
    Br J Dermatol; 2007 Aug; 157(2):344-9. PubMed ID: 17553037
    [Abstract] [Full Text] [Related]

  • 3. Melanoma and non-melanoma skin cancer in psoriatic patients treated with high-dose phototherapy.
    Maiorino A, De Simone C, Perino F, Caldarola G, Peris K.
    J Dermatolog Treat; 2016 Oct; 27(5):443-7. PubMed ID: 26822468
    [Abstract] [Full Text] [Related]

  • 4. No evidence for increased skin cancer risk in Koreans with skin phototypes III-V treated with narrowband UVB phototherapy.
    Jo SJ, Kwon HH, Choi MR, Youn JI.
    Acta Derm Venereol; 2011 Jan; 91(1):40-3. PubMed ID: 21031281
    [Abstract] [Full Text] [Related]

  • 5. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
    Wang E, Ahad T, Liu YA, Lee TK, Lui H, Crawford RI, Kalia S.
    J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
    [Abstract] [Full Text] [Related]

  • 6. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
    Hearn RM, Kerr AC, Rahim KF, Ferguson J, Dawe RS.
    Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
    [Abstract] [Full Text] [Related]

  • 7. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
    Bae JM, Ju HJ, Lee RW, Oh SH, Shin JH, Kang HY, Park JH, Kim HJ, Jeong KH, Lee HJ, Lee S, Kim DH, Lee DY, Kim YC, Choi GS, Kim KH, Park CJ, Choi CW, Korean Society of Vitiligo.
    JAMA Dermatol; 2020 May 01; 156(5):529-537. PubMed ID: 32159729
    [Abstract] [Full Text] [Related]

  • 8. The photocarcinogenic risk of narrowband UVB (TL-01) phototherapy: early follow-up data.
    Man I, Crombie IK, Dawe RS, Ibbotson SH, Ferguson J.
    Br J Dermatol; 2005 Apr 01; 152(4):755-7. PubMed ID: 15840109
    [Abstract] [Full Text] [Related]

  • 9. Incidence of skin malignancies in patients with vitiligo or psoriasis who received narrowband ultraviolet B phototherapy (308 nm/311 nm): A retrospective review of 3730 patients.
    Chia BKY, Yew YW, Zhao X, Chong WS, Thng TGS.
    Photodermatol Photoimmunol Photomed; 2023 Jul 01; 39(4):343-350. PubMed ID: 36345565
    [Abstract] [Full Text] [Related]

  • 10. Incidence of non-melanoma skin cancer in patients treated with psoralen and ultraviolet A therapy.
    Ortiz Salvador JM, Pérez-Ferriols A, Alegre de Miquel V, Saneleuterio Temporal M, Vilata Corell JJ.
    Med Clin (Barc); 2019 Jun 21; 152(12):488-492. PubMed ID: 30503067
    [Abstract] [Full Text] [Related]

  • 11. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
    Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA.
    J Eur Acad Dermatol Venereol; 2012 May 21; 26 Suppl 3():22-31. PubMed ID: 22512677
    [Abstract] [Full Text] [Related]

  • 12. Is it Useful to Calculate Minimal Erythema Dose Before Narrowband UV-B Phototherapy?
    Rodríguez-Granados MT, Estany-Gestal A, Pousa-Martínez M, Labandeira J, Gato Otero R, Fernández-Redondo V.
    Actas Dermosifiliogr; 2017 Nov 21; 108(9):852-858. PubMed ID: 28687116
    [Abstract] [Full Text] [Related]

  • 13. Photocarcinogenic risk of narrowband ultraviolet B (TL-01) phototherapy: early follow-up data.
    Black RJ, Gavin AT.
    Br J Dermatol; 2006 Mar 21; 154(3):566-7. PubMed ID: 16445801
    [No Abstract] [Full Text] [Related]

  • 14. A cross-sectional analysis of skin cancer risk in patients receiving narrow-band ultraviolet B phototherapy: an evaluation of 100 patients.
    Karaosmanoglu N, Ozdemir Cetinkaya P, Kutlu O, Karaaslan E, Imren IG, Kiratli Nalbant E, Eksioglu M.
    Arch Dermatol Res; 2020 May 21; 312(4):249-253. PubMed ID: 31729594
    [Abstract] [Full Text] [Related]

  • 15. Generalized Licen Planus Treated With Narrowband UV-B Phototherapy: Results From 10 Patients and a Review of the Literature.
    Fernández-Guarino M, Aboín S, Barchino L, Arsuaga C, Lázaro Ochaita P.
    Actas Dermosifiliogr (Engl Ed); 2019 May 21; 110(6):490-493. PubMed ID: 30987737
    [Abstract] [Full Text] [Related]

  • 16. Ultraviolet B phototherapy does not increase the risk of skin cancer among patients with atopic dermatitis: A population-based retrospective cohort study.
    Ko MJ, Tsai WC, Tsai PH, Hsu LY, Chien KL, Wu HY.
    J Am Acad Dermatol; 2023 Sep 21; 89(3):496-503. PubMed ID: 37236426
    [Abstract] [Full Text] [Related]

  • 17. Risk of skin cancer in psoriasis patients receiving long-term narrowband ultraviolet phototherapy: Results from a Taiwanese population-based cohort study.
    Lin TL, Wu CY, Chang YT, Juan CK, Chen CC, Yu SH, Chen YJ.
    Photodermatol Photoimmunol Photomed; 2019 May 21; 35(3):164-171. PubMed ID: 30536640
    [Abstract] [Full Text] [Related]

  • 18. Cutaneous carcinogenic risk evaluation in 375 patients treated with narrowband-UVB phototherapy: A 15-year experience from our Institute.
    Raone B, Patrizi A, Gurioli C, Gazzola A, Ravaioli GM.
    Photodermatol Photoimmunol Photomed; 2018 Sep 21; 34(5):302-306. PubMed ID: 29533483
    [Abstract] [Full Text] [Related]

  • 19. Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial.
    Lim HW, Grimes PE, Agbai O, Hamzavi I, Henderson M, Haddican M, Linkner RV, Lebwohl M.
    JAMA Dermatol; 2015 Jan 21; 151(1):42-50. PubMed ID: 25230094
    [Abstract] [Full Text] [Related]

  • 20. Malignancy rates in a large cohort of patients with systemically treated psoriasis in a managed care population.
    Asgari MM, Ray GT, Geier JL, Quesenberry CP.
    J Am Acad Dermatol; 2017 Apr 21; 76(4):632-638. PubMed ID: 28162854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.